1. Home
  2. COLD vs TVTX Comparison

COLD vs TVTX Comparison

Compare COLD & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Americold Realty Trust Inc.

COLD

Americold Realty Trust Inc.

HOLD

Current Price

$14.59

Market Cap

4.6B

Sector

Real Estate

ML Signal

HOLD

Logo Travere Therapeutics Inc.

TVTX

Travere Therapeutics Inc.

HOLD

Current Price

$67.23

Market Cap

5.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
COLD
TVTX
Founded
1903
N/A
Country
United States
United States
Employees
12690
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.6B
5.3B
IPO Year
2009
2013

Fundamental Metrics

Financial Performance
Metric
COLD
TVTX
Price
$14.59
$67.23
Analyst Decision
Hold
Strong Buy
Analyst Count
16
13
Target Price
$14.97
$40.62
AVG Volume (30 Days)
3.1M
1.6M
Earning Date
05-07-2026
05-04-2026
Dividend Yield
7.67%
N/A
EPS Growth
N/A
92.89
EPS
N/A
N/A
Revenue
$2,601,846,000.00
N/A
Revenue This Year
N/A
$44.76
Revenue Next Year
$2.86
$35.51
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.10
$19.46
52 Week High
$16.88
$67.85

Technical Indicators

Market Signals
Indicator
COLD
TVTX
Relative Strength Index (RSI) 44.16 64.48
Support Level $13.84 $53.76
Resistance Level $15.45 N/A
Average True Range (ATR) 0.37 1.98
MACD -0.03 -0.06
Stochastic Oscillator 17.39 89.97

Price Performance

Historical Comparison
COLD
TVTX

About COLD Americold Realty Trust Inc.

Americold Realty Trust Inc is the world's second-largest owner and operator of temperature-controlled warehouses behind privately held Lineage Logistics. The Atlanta, Georgia-based firm owns and operates approximately 231 temperature-controlled warehouses, spanning 1.4 billion cubic feet. In 2022, the firm derived more than 80% of its revenue from the United States but also has sizable operations in Europe, Canada, Australia, and New Zealand. Americold supplements its core business by providing supply management and transportation services to its various customers. It operates as a real estate investment trust.

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease. It is also advancing pegtibatinase, a novel investigational enzyme replacement therapy for the treatment of HCU, a genetic disorder caused by a deficiency in a pivotal enzyme essential to the body.

Share on Social Networks: